REPLIGEN CORP Machinery and Equipment, Gross
REPLIGEN CORP (RGEN) had Machinery and Equipment, Gross of $147.47 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:MachineryAndEquipmentGross · last filed 2026-02-26
- 2025-12-31: Machinery and Equipment, Gross $147.47M.
- 2025-09-30: Machinery and Equipment, Gross $144.30M.
- 2025-06-30: Machinery and Equipment, Gross $140.63M.
- 2025-03-31: Machinery and Equipment, Gross $135.07M.
| Period end | Machinery and Equipment, Gross | Machinery and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $147.47M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $144.30M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $140.63M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $135.07M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $130.41M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $120.03M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $114.01M 10-Q/A · filed 2024-11-18 | |
| 2024-03-31 | $113.80M 10-Q/A · filed 2024-11-18 | |
| 2023-12-31 | $114.61M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $111.63M 10-Q/A · filed 2024-11-18 | |
| 2023-06-30 | $110.05M 10-Q/A · filed 2024-11-18 | |
| 2023-03-31 | $99.05M 10-Q/A · filed 2024-11-18 | |
| 2022-12-31 | $94.61M 10-Q/A · filed 2024-11-18 | |
| 2022-09-30 | $80.40M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $75.13M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $73.45M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $70.98M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $65.76M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $52.48M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $44.10M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $43.07M 10-K · filed 2022-02-17 | |
| 2020-09-30 | $39.09M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $37.81M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $36.99M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $36.26M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $31.14M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $30.50M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $26.33M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $24.09M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $23.41M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $23.20M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $22.50M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $21.90M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $19.54M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $16.47M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $15.50M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $15.21M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $14.75M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $14.68M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $14.42M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $13.76M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $13.51M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $13.53M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $12.98M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $13.12M 10-K · filed 2016-02-25 | $13.12M 10-K · filed 2015-03-17 |
| 2014-09-30 | $13.94M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $14.17M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $13.94M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $13.68M 10-K · filed 2015-03-17 | |
| 2013-09-30 | $13.49M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $12.91M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $12.96M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $12.80M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $12.65M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $11.97M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $12.30M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $12.01M 10-K · filed 2013-03-15 | $11.40M 10-K · filed 2012-03-15 |
| 2011-09-30 | $4.76M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $4.59M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $4.43M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |